bso cancer treatment glutathione

bso cancer treatment glutathione Human cancer-associated fibroblasts enhance levels and antagonize drug-induced prostate cell death Glutathione and Thioredoxin Antioxidant Pathways

Name: bso cancer treatment glutathione Human cancer-associated fibroblasts enhance levels and antagonize drug-induced prostate cell death Glutathione and Thioredoxin Antioxidant Pathways
Brand: condeoeiras.edu.pt
SKU: 52826677892
Price: 28.46 USD
Availability: InStock
Rating: 4.5877 (30 reviews)

Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression ScienceDirect Unraveling the Potential Role of Glutathione in Multiple Forms of Cell Death in Cancer Therapy Lv 2019 Oxidative Medicine and Cellular Longevity Wiley Online Library Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression: Cancer Cell Glutathione dynamics is a potential predictive and therapeutic trait for neoadjuvant chemotherapy response in bladder cancer: Cell Reports Medicine Inhibiting glutathione synthesis sensitizes breast cancer cells to Download Scientific Diagram Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor 2 Expressing Pre Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu DOTATATE

SKU: 52826677892 · From condeoeiras.edu.pt

4.6

USD28.46 USD68.46

Pay in 4 interest-free payments of $7.12 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Additional information Size 100MG AHK-Cu is a copper-binding tripeptide commonly referenced in laboratory and formulation research involving peptidemetal complexes